Article

Prescription drug pricing: The times they are a changin’

The political mood in the US on drug pricing at a national and state level is putting the pressure on pharma to demonstrate value

Putting a price on life: Is the answer outside pharma?

Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthc...

Putting The I in Pills

Individualised medicine has so far failed to live up to the hype but innovations in the field are on the cusp of disrupting the way pharma a...

Embracing Early Access

Compassionate use programs offer hope to patients who have ran out of options. But the benefits must be weighed against the risks.

RWE: The Missing Link

Linking real-world datasets is essential to deliver true insights

Access and Evidence

Latest Articles

Prescription drug pricing: The times they are a changin’

Ulrich Neumann, (Nov 25, 2019)

The political mood in the US on drug pricing at a national and state level is putting the pressure on pharma to demonstrate value
Putting a price on life: Is the answer outside pharma?

Nicola Davies, (Nov 4, 2019)

Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthcare advancements suggests maybe not.
Putting The I in Pills

Izzy Gladstone, (Jun 27, 2019)

Individualised medicine has so far failed to live up to the hype but innovations in the field are on the cusp of disrupting the way pharma and healthcare develop and provide treatments.
Embracing Early Access

Katie Osborne, (Jan 22, 2019)

Compassionate use programs offer hope to patients who have ran out of options. But the benefits must be weighed against the risks.
RWE: The Missing Link

Nicola Davies, (Jan 7, 2019)

Linking real-world datasets is essential to deliver true insights
Gold Standard: Standardizing RWD

Nicola Davies, (Jan 4, 2019)

If real-world data is to deliver on its promise, it needs to be standardized
Blockchain: Solution Or Snake Oil?

Ross Davies, (Dec 19, 2018)

The potential of blockchain to better manage RWE and access makes it an exciting prospect. However, pharma first needs to get its head around the practical application.
VBCs: Are They Working?

Adam Chapman, (Dec 12, 2018)

Are value-based contracts actually improving patient access to new medicines?
Calling the Shots?

Katie Osborne, (Dec 10, 2018)

How influential are the value assessments from bodies like ICER?
Cutting Out the Middleman

Hugh Gosling, (Dec 7, 2018)

Are PBMs part of the problem or the solution?